Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade.
Hermanns T, Savio AJ, Olkhov-Mitsel E, Mari A, Wettstein MS, Saba K, Bhindi B, Kuk C, Poyet C, Wild PJ, Noon A, Bashir S, Juvet T, Rendon RA, Waltregny D, van der Kwast T, Finelli A, Kulkarni GS, Fleshner NE, Lo K, Bapat B, Zlotta AR. Hermanns T, et al. Among authors: mari a. Urol Oncol. 2020 Jun;38(6):603.e1-603.e7. doi: 10.1016/j.urolonc.2020.01.007. Epub 2020 Feb 18. Urol Oncol. 2020. PMID: 32081560
Progressive tissue biomarker profiling in non-muscle-invasive bladder cancer.
D'Andrea D, Hassler MR, Abufaraj M, Soria F, Ertl IE, Ilijazi D, Mari A, Foerster B, Egger G, Shariat SF. D'Andrea D, et al. Among authors: mari a. Expert Rev Anticancer Ther. 2018 Jul;18(7):695-703. doi: 10.1080/14737140.2018.1474104. Epub 2018 May 9. Expert Rev Anticancer Ther. 2018. PMID: 29737231 Review.
Sequential administration of Bacillus Calmette-Guerin (BCG) and Electromotive Drug Administration (EMDA) of mitomycin C (MMC) for the treatment of high-grade nonmuscle invasive bladder cancer after BCG failure.
Juvet T, Mari A, Lajkosz K, Wallis CJ, Kuk C, Erlich A, Krimus L, Fleshner NE, Kulkarni GS, Zlotta AR. Juvet T, et al. Among authors: mari a. Urol Oncol. 2020 Nov;38(11):850.e9-850.e15. doi: 10.1016/j.urolonc.2020.06.031. Epub 2020 Jul 23. Urol Oncol. 2020. PMID: 32712139
Incidence, risk factors and outcomes of urethral recurrence after radical cystectomy for bladder cancer: A systematic review and meta-analysis.
Laukhtina E, Mori K, D Andrea D, Moschini M, Abufaraj M, Soria F, Mari A, Krajewski W, Albisinni S, Teoh JY, Quhal F, Sari Motlagh R, Mostafaei H, Katayama S, Grossmann NС, Rajwa P, Enikeev D, Zimmermann K, Fajkovic H, Glybochko P, Shariat SF, Pradere B; European Association of Urology–Young Academic Urologists Urothelial Carcinoma Working Group (EAU-YAU). Laukhtina E, et al. Among authors: mari a. Urol Oncol. 2021 Dec;39(12):806-815. doi: 10.1016/j.urolonc.2021.06.009. Epub 2021 Jul 13. Urol Oncol. 2021. PMID: 34266740 Free article.
Postoperative Chemotherapy Bladder Instillation After Radical Nephroureterectomy: Results of a European Survey from the Young Academic Urologist Urothelial Cancer Group.
Dobé TR, Califano G, von Rundstedt FC, Ouzaid I, Albisinni S, Aziz A, Di Trapani E, Hendricksen K, Krajewski W, Mari A, Moschini M, Necchi A, Noon AP, Poyet C, Pradère B, Rink M, Roghmann F, Sargos P, Seiler R, Soria F, Vetterlein MW, Xylinas E. Dobé TR, et al. Among authors: mari a. Eur Urol Open Sci. 2020 Nov 6;22:45-50. doi: 10.1016/j.euros.2020.10.003. eCollection 2020 Dec. Eur Urol Open Sci. 2020. PMID: 34337476 Free PMC article.
Fighting the 'tobacco epidemic' - A call to action to identify Targeted Intervention Points (TIPs) for better counseling patients with urothelial cancer.
Cacciamani GE, Matulewicz RS, Kumar R, Teoh JY, Mari A, Pradere B, Gomez Rivas J, Necchi A, Kumar Pal S, Ribal MJ, Shariat S, Rink M; SMART (Stop sMoking for Advance Rehabilitation Treatments) Urology Working Group. Cacciamani GE, et al. Among authors: mari a. Urol Oncol. 2021 Dec;39(12):793-796. doi: 10.1016/j.urolonc.2021.08.025. Epub 2021 Oct 8. Urol Oncol. 2021. PMID: 34629283
1,144 results